At the time of writing, Tango Therapeutics Inc [TNGX] stock is trading at $11.68, up 7.75%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The TNGX shares have gain 3.00% over the last week, with a monthly amount glided 29.63%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Tango Therapeutics Inc [NASDAQ: TNGX] stock has seen the most recent analyst activity on July 17, 2024, when Jefferies initiated its Buy rating and assigned the stock a price target of $19. On February 12, 2024, Piper Sandler initiated with a Overweight rating and assigned a price target of $18 on the stock. B. Riley Securities started tracking the stock assigning a Buy rating and suggested a price target of $16 on December 08, 2023. H.C. Wainwright upgraded its rating to a Buy but $10 remained the price target by the analyst firm on October 20, 2022. SVB Leerink started tracking with a Outperform rating for this stock on September 20, 2021, and assigned it a price target of $25.
For the past year, the stock price of Tango Therapeutics Inc fluctuated between $5.15 and $13.03. Currently, Wall Street analysts expect the stock to reach $13 within the next 12 months. Tango Therapeutics Inc [NASDAQ: TNGX] shares were valued at $11.68 at the most recent close of the market. An investor can expect a potential return of 11.3% based on the average TNGX price forecast.
Analyzing the TNGX fundamentals
According to Tango Therapeutics Inc [NASDAQ:TNGX], the company’s sales were 42.51M for trailing twelve months, which represents an 36.15% jump. Gross Profit Margin for this corporation currently stands at 0.94% with Operating Profit Margin at -3.12%, Pretax Profit Margin comes in at -2.74%, and Net Profit Margin reading is -2.74%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is -0.45 and Total Capital is -0.39. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.90 points at the first support level, and at 10.13 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.12, and for the 2nd resistance point, it is at 12.57.
Ratios To Look Out For
It is important to note that Tango Therapeutics Inc [NASDAQ:TNGX] has a current ratio of 7.49. Also, the Quick Ratio is 7.49, while the Cash Ratio stands at 1.18. Considering the valuation of this stock, the price to sales ratio is 29.44, the price to book ratio is 5.05.
Transactions by insiders
Recent insider trading involved Third Rock Ventures IV, L.P., Affiliate, that happened on Sep 05 ’24 when 75000.0 shares were purchased. 10% Owner, Third Rock Ventures IV, L.P. completed a deal on Aug 30 ’24 to sell 0.17 million shares. Meanwhile, Affiliate Third Rock Ventures IV, L.P. bought 0.17 million shares on Aug 30 ’24.
